org placeholder image

Ian Critchley

Vice President, Head of Clinical Microbiology at Spero Therapeutics

  • LinkedIn
map
SPERO THERAPEUTICS

SPERO THERAPEUTICS

  • description Description
    We are a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for bacterial infections, including multi-drug resistant...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 100 Million to 250 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Spero Therapeutics Org Chart and Mapping

Employees

Netaya Kevorkian

Quality Assurance Specialist

John Lenihan

Director, Assistant Controller

David Hong

Vice President, Clinical Development

Sobiya Jesudasan

Clinical Operations Consultant

Ian Critchley

Vice President, Head of Clinical Microbiology

Alicia Geiter

Senior Clinical Research Associate

Frequently Asked Questions Regarding Ian Critchley

Answer: Ian Critchley works for Spero Therapeutics as Vice President, Head of Clinical Microbiology

Answer: Ian Critchley’s role in Spero Therapeutics is Vice President, Head of Clinical Microbiology

Answer: Ian Critchley's email address is i***@gmail.com

Answer: Ian Critchley's business email address is i****@sperotherapeutics.com

Answer: Ian Critchley’s direct phone number is (***)-***-****

Answer: Ian Critchley works in the industry of: Biotechnology

Answer: Ian Critchley works Spero Therapeutics located at 675 Ave, Cambridge, Massachusetts, 02139, United States

Answer: Spero Therapeutics's Vice President, Head of Clinical Microbiology is Ian Critchley

Answer: Ian Critchley contact details:

  • Phone number  :  (***)-***-****
  • Email  :  i****@sperotherapeutics.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access